Trial intelligence / Profile preview

E6005 in Japanese Patients With Atopic Dermatitis

NCT01179880Phase 2Completed

Sponsor
Organon & Co.
Start
Sep 2010
Primary completion
Dec 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of lotamilast in atopic dermatitis (AD), sponsored by Organon & Co.. Started Sep 2010; status: completed.

02

Drugs

lotamilast
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on NCT01179880.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01179880.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call